Kamu erişimi zorunlu olan makaleler - Dinesh KadariyaDaha fazla bilgi edinin
Hiçbir yerde sunulmuyor: 1
Safety, Tolerability, and Effects of a Single Subcutaneous Administration of SP16–a SERPIN-like, Small Peptide Agonist of the Low-Density Lipoprotein–like Receptor 1–on the …
BW Van Tassell, GF Wohlford, MG Del Buono, JI Damonte, R Markley, ...
Journal of Cardiovascular Pharmacology 80 (5), 672-678, 2022
Zorunlu olanlar: US National Institutes of Health
Bir yerde sunuluyor: 35
Interleukin‐1 blockade inhibits the acute inflammatory response in patients with ST‐segment–elevation myocardial infarction
A Abbate, CR Trankle, LF Buckley, MJ Lipinski, D Appleton, D Kadariya, ...
Journal of the American Heart Association 9 (5), e014941, 2020
Zorunlu olanlar: US National Institutes of Health
Interleukin-1 blockade in recently decompensated systolic heart failure: results from REDHART (Recently Decompensated Heart Failure Anakinra Response Trial)
BW Van Tassell, J Canada, S Carbone, C Trankle, L Buckley, ...
Circulation: Heart Failure 10 (11), e004373, 2017
Zorunlu olanlar: US National Institutes of Health
Il-1 blockade in patients with heart failure with preserved ejection fraction: Results from dhart2
BW Van Tassell, CR Trankle, JM Canada, S Carbone, L Buckley, ...
Circulation: Heart Failure 11 (8), e005036, 2018
Zorunlu olanlar: US National Institutes of Health
IL-1 blockade reduces inflammation in pulmonary arterial hypertension and right ventricular failure: a single-arm, open-label, phase IB/II pilot study
CR Trankle, JM Canada, D Kadariya, R Markley, HM De Chazal, J Pinson, ...
American journal of respiratory and critical care medicine 199 (3), 381-384, 2019
Zorunlu olanlar: US National Institutes of Health, National Health and Medical Research …
Phase 1b, randomized, double-blinded, dose escalation, single-center, repeat dose safety and pharmacodynamics study of the oral nlrp3 inhibitor dapansutrile in subjects with …
GF Wohlford, BW Van Tassell, HE Billingsley, D Kadariya, S Carbone, ...
Journal of cardiovascular pharmacology 77 (1), 49-60, 2021
Zorunlu olanlar: US National Institutes of Health, American Heart Association
Dietary fat, sugar consumption, and cardiorespiratory fitness in patients with heart failure with preserved ejection fraction
S Carbone, JM Canada, LF Buckley, CR Trankle, HE Billingsley, ...
Basic to Translational Science 2 (5), 513-525, 2017
Zorunlu olanlar: US National Institutes of Health, American Heart Association, Patient …
Interleukin-1 blockade with anakinra and heart failure following ST-segment elevation myocardial infarction: results from a pooled analysis of the VCUART clinical trials
A Abbate, GF Wohlford, MG Del Buono, JG Chiabrando, R Markley, ...
European Heart Journal-Cardiovascular Pharmacotherapy 8 (5), 503-510, 2022
Zorunlu olanlar: US National Institutes of Health, American Heart Association
Usefulness of canakinumab to improve exercise capacity in patients with long-term systolic heart failure and elevated C-reactive protein
CR Trankle, JM Canada, L Cei, N Abouzaki, C Oddi-Erdle, D Kadariya, ...
The American journal of cardiology 122 (8), 1366-1370, 2018
Zorunlu olanlar: US National Institutes of Health
Low NT‐proBNP levels in overweight and obese patients do not rule out a diagnosis of heart failure with preserved ejection fraction
LF Buckley, JM Canada, MG Del Buono, S Carbone, CR Trankle, ...
ESC heart failure 5 (2), 372-378, 2018
Zorunlu olanlar: US National Institutes of Health
Rationale and design of the Virginia Commonwealth University–Anakinra Remodeling Trial‐3 (VCU‐ART3): A randomized, placebo‐controlled, double‐blinded, multicenter study
BW Van Tassell, MJ Lipinski, D Appleton, CS Roberts, MC Kontos, ...
Clinical cardiology 41 (8), 1004-1008, 2018
Zorunlu olanlar: US National Institutes of Health
The effects of canagliflozin compared to sitagliptin on cardiorespiratory fitness in type 2 diabetes mellitus and heart failure with reduced ejection fraction: The CANA‐HF study
S Carbone, HE Billingsley, JM Canada, E Bressi, B Rotelli, D Kadariya, ...
Diabetes/Metabolism Research and Reviews 36 (8), e3335, 2020
Zorunlu olanlar: US National Institutes of Health, American Heart Association
Alirocumab in acute myocardial infarction: results from the Virginia commonwealth university alirocumab response trial (VCU-AlirocRT)
CR Trankle, G Wohlford, LF Buckley, D Kadariya, K Ravindra, R Markley, ...
Journal of cardiovascular pharmacology 74 (3), 266-269, 2019
Zorunlu olanlar: US National Institutes of Health
Relation of hepatic fibrosis in nonalcoholic fatty liver disease to left ventricular diastolic function and exercise tolerance
JMN Canada, A Abbate, R Collen, H Billingsley, LF Buckley, S Carbone, ...
The American journal of cardiology 123 (3), 466-473, 2019
Zorunlu olanlar: US National Institutes of Health
Sarcopenic obesity is associated with reduced cardiorespiratory fitness compared with nonsarcopenic obesity in patients with heart failure with reduced ejection fraction
HE Billingsley, MG Del Buono, JM Canada, Y Kim, JI Damonte, ...
Circulation: Heart Failure 15 (10), e009518, 2022
Zorunlu olanlar: US National Institutes of Health, American Heart Association
Effect of interleukin-1 blockade with anakinra on leukocyte count in patients with ST-segment elevation acute myocardial infarction
MG Del Buono, JI Damonte, CR Trankle, D Kadariya, S Carbone, ...
Scientific Reports 12 (1), 1254, 2022
Zorunlu olanlar: US National Institutes of Health
C-reactive protein and N-terminal pro-brain natriuretic peptide levels correlate with impaired cardiorespiratory fitness in patients with heart failure across a wide range of …
J Van Wezenbeek, JM Canada, K Ravindra, S Carbone, CR Trankle, ...
Frontiers in cardiovascular medicine 5, 178, 2018
Zorunlu olanlar: US National Institutes of Health
Effects of empagliflozin on cardiorespiratory fitness and significant interaction of loop diuretics
S Carbone, JM Canada, HE Billingsley, D Kadariya, DL Dixon, ...
Diabetes, Obesity and Metabolism 20 (8), 2014-2018, 2018
Zorunlu olanlar: US National Institutes of Health, American Heart Association
Effect of interleukin-1 blockade on left ventricular systolic performance and work: a post hoc pooled analysis of 2 clinical trials
LF Buckley, S Carbone, CR Trankle, CO Erdle, JA Regan, MM Viscusi, ...
Journal of cardiovascular pharmacology 72 (1), 68-70, 2018
Zorunlu olanlar: US National Institutes of Health
Determinants of cardiorespiratory fitness following thoracic radiotherapy in lung or breast cancer survivors
JM Canada, CR Trankle, S Carbone, LF Buckley, M de Chazal, ...
The American journal of cardiology 125 (6), 988-996, 2020
Zorunlu olanlar: US National Institutes of Health
Yayıncılık ve maddi kaynak bilgileri otomatik olarak bir bilgisayar programı tarafından belirlenmektedir